Literature DB >> 28438669

The effects of Chinese medicines on cAMP/PKA signaling in central nervous system dysfunction.

Lin Li1, Xiang Fan1, Xi-Ting Zhang1, Shao-Qian Yue1, Zuo-Yan Sun1, Jin-Qiang Zhu1, Jun-Hua Zhang2, Xiu-Mei Gao1, Han Zhang3.   

Abstract

Neuropathological injury in the mammalian adult central nervous system (CNS) may cause axon disruption, neuronal death and lasting neurological deficits. Failure of axon regeneration is one of the major challenges for CNS functional recovery. Recently, the cAMP/PKA signaling pathway has been proven to be a critical regulator for neuronal regeneration, neuroplasticity, learning and memory. Also, previous studies have shown the effects of Chinese medicines on the prevention and treatment of CNS dysfunction mediated in part by cAMP/PKA signaling. In this review, the authors discuss current knowledge of the role of cAMP/PKA signaling pathway in neuronal regeneration and provide an overview of the Chinese medicines that may enable CNS functional recovery via this signaling pathway.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chinese medicines; Cyclic AMP (cAMP); Neuronal regeneration; Protein kinase A (PKA)

Mesh:

Substances:

Year:  2017        PMID: 28438669     DOI: 10.1016/j.brainresbull.2017.04.006

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  2 in total

1.  Overexpressed HspB6 Underlines a Novel Inhibitory Role in Kainic Acid-Induced Epileptic Seizure in Rats by Activating the cAMP-PKA Pathway.

Authors:  Ai-Qin Qi; Yan-Hui Zhang; Qin-De Qi; Ye-Hui Liu; Jun-Ling Zhu
Journal:  Cell Mol Neurobiol       Date:  2018-12-03       Impact factor: 5.046

2.  Neurobehavioral and Biochemical Evidences in Support of Protective Effect of Marrubiin (Furan Labdane Diterpene) from Marrubium vulgare Linn. and Its Extracts after Traumatic Brain Injury in Experimental Mice.

Authors:  Govind Singh; Rekha Valecha; Govind Shukla; Deepak Kaushik; Mohammad Akhlaquer Rahman; Rupesh K Gautam; Kumud Madan; Vineet Mittal; Rajeev K Singla
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-24       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.